Document is current

Article History

Received: 1 May 2024

Accepted: 31 July 2024

First Online: 23 August 2024

Declarations

:

: April W. Armstrong has served as a research investigator, scientific advisor, and/or speaker for AbbVie, Almirall, Arcutis, ASLAN, Beiersdoft, BI, BMS, EPI, Incyte, LEO, UCB, Janssen, Lilly, Mindera, Nimbus, Novartis, Ortho Dermatologics, Sun, Dermavant, Dermira, Sanofi, Regeneron, and Pfizer. Peter Foley has received grant support and/or travel grants and/or honoraria from and/or served as an investigator and/or advisory board member and/or consultant and/or speaker for AbbVie, Akaal, Amgen, Arcutis, Argenx, Aslan, AstraZeneca, Boehringer Ingelheim, Botanix, Bristol-Myers Squibb, Celgene, Celtaxsys, CSL, CSL Seqirus, Cutanea, Dermira, Eli Lilly, Evelo Biosciences, Galderma, Genentech, GenesisCare, GlaxoSmithKline, Hexima, Incyte, Janssen, Kymab, LEO Pharma, Mayne Pharma, MedImmune, Melaseq/Geneseq, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., Reistone, Roche, Sanofi, Sun Pharma, Teva, UCB Pharma, and Valeant. Anthony Bewley has received ad hoc consultancy and/or travel bursaries from Abbvie, Almirall, Galderma, Leo Pharma, Lilly, Janssen, Novartis, Pfizer, Sanofi, and UCB. Kenneth B. Gordon has received research/grant support and/or honoraria for consultation from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Eli Lilly, Janssen, Novartis, and UCB Pharma. Kim A. Papp has received clinical research grants and/or honoraria as a consultant, and/or speaker, and/or investigator, and/or scientific officer, and/or advisory board member, and/or Steering Committee member for AbbVie, Akros, Amgen, Anacor, Arcutis, Astellas, Avillion, Bausch Health/Valeant, Baxalta, Boehringer Ingelheim, Bristol-Myers Squibb, Can-Fite Biopharma, Celgene, Coherus, Dermavant, Dermira, Dow Pharma, Eli Lilly, Evelo, Galapagos, Galderma, Genentech, Gilead, GSK, Incyte, Janssen, Kyowa Hakko Kirin, Leo, Medimmune, Meiji Seika Pharma, Merck (MSD), Merck-Serono, Mitsubishi Pharma, Moberg Pharma, Novartis, Pfizer, PRCL Research, Regeneron, Roche, Sanofi-Aventis/Genzyme, Sun Pharma, Takeda and UCB. Rachel E. Teneralli, and Chenglong Han are employees of Janssen Global Services, LLC, Ya-Wen Yang is an employee of Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, and Megan Miller is an employee of Janssen Research & Development, LLC; employees may own stock in Johnson & Johnson, of which Janssen is a subsidiary. Yan Liu was an employee of Janssen Global Services, LLC, at the time this study was conducted.

: This article is based on data from previously conducted studies, VOYAGE 1 (NCT02207231) and VOYAGE 2 (NCT 02207244), which were conducted in accordance with the Declaration of Helsinki and were consistent with good clinical practices and regulatory requirements. Patients provided written informed consent prior to enrollment in either trial.